Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin Injection for Distributive Shock Hypotension (Phase 3, China)
ChiCTR2200061190Phase 3Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- May 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Vasoplegia and hypotension comparing Norepinephrine + Vasopressin Injection with Norepinephrine + Placebo (2 arms). Primary endpoint: Laboratory tests. Started May 2022; status: recruiting.
02
Drugs
vasopressin
03
Conditions
Vasoplegiahypotension
Beyond the preview
Go deeper on ChiCTR2200061190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061190.